Review
doi: 10.1161/CIRCULATIONAHA.106.685974.
Beyond unfractionated heparin and warfarin: current and future advances
Affiliations
- PMID: 17664384
- DOI: 10.1161/CIRCULATIONAHA.106.685974
Item in Clipboard
Review
Beyond unfractionated heparin and warfarin: current and future advances
Circulation.
.
No abstract available
Similar articles
-
Old versus new anticoagulants: focus on pharmacology.Recent Pat Cardiovasc Drug Discov. 2010 Jun;5(2):120-37. doi: 10.2174/157489010791515269. Recent Pat Cardiovasc Drug Discov. 2010. PMID: 20337579 Review.
-
The promise of novel direct oral anticoagulants.Best Pract Res Clin Haematol. 2012 Sep;25(3):351-60. doi: 10.1016/j.beha.2012.06.004. Epub 2012 Jul 31. Best Pract Res Clin Haematol. 2012. PMID: 22959551 Review.
-
[From heparin to apixaban: anticoagulants cut both ways?].Zentralbl Chir. 2014 Feb;139(1):89-97. doi: 10.1055/s-0032-1328004. Epub 2013 Mar 4. Zentralbl Chir. 2014. PMID: 23460104 Review. German.
-
[New clinical perspectives in the management of oral direct anticoagulant agents].Med Clin (Barc). 2014 Feb 20;142(4):171-8. doi: 10.1016/j.medcli.2013.05.002. Epub 2013 Jul 16. Med Clin (Barc). 2014. PMID: 23866969 Review. Spanish. No abstract available.
-
Current and future prospects for anticoagulant therapy: inhibitors of factor Xa and factor IIa.Semin Thromb Hemost. 2008 Feb;34(1):39-57. doi: 10.1055/s-2008-1066023. Semin Thromb Hemost. 2008. PMID: 18393142 Review.
Cited by
-
Current and future strategies to monitor and manage coagulation in ECMO patients.Thromb J. 2023 Jan 26;21(1):11. doi: 10.1186/s12959-023-00452-z. Thromb J. 2023. PMID: 36703184 Free PMC article. Review.
-
The proof for new oral anticoagulants: clinical trial evidence.Eur Orthop Traumatol. 2011 Jul;2(1-2):7-14. doi: 10.1007/s12570-011-0063-9. Epub 2011 May 19. Eur Orthop Traumatol. 2011. PMID: 21892362 Free PMC article.
-
Venous thromboembolism in the elderly. A community-based perspective.Thromb Haemost. 2008 Nov;100(5):780-8. Thromb Haemost. 2008. PMID: 18989521 Free PMC article.
-
Analogs of N'-hydroxy-N-(4H,5H-naphtho[1,2-d]thiazol-2-yl)methanimidamide inhibit Mycobacterium tuberculosis methionine aminopeptidases.Bioorg Med Chem. 2012 Jul 15;20(14):4507-13. doi: 10.1016/j.bmc.2012.05.022. Epub 2012 May 17. Bioorg Med Chem. 2012. PMID: 22704656 Free PMC article.
-
Bioassay-guided fractionation of Melastoma malabathricum Linn. leaf solid phase extraction fraction and its anticoagulant activity.Molecules. 2015 Feb 24;20(3):3697-715. doi: 10.3390/molecules20033697. Molecules. 2015. PMID: 25719740 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
